Advanced search
Publication Cover
Biomarkers Volume 18, 2013 - Issue 2
Submit an article Journal homepage
204
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes

Zi-Wen ZhaoDepartment of Cardiology, Union Hospital, Fujian Institute of Coronary Artery Disease, Fujian Medical University FuzhouP. R. China
,
Chao-Gui LinDepartment of Cardiology, Union Hospital, Fujian Institute of Coronary Artery Disease, Fujian Medical University FuzhouP. R. China
,
Ling-Zhen WuDepartment of Cardiology, Union Hospital, Fujian Institute of Coronary Artery Disease, Fujian Medical University FuzhouP. R. China
,
Yu-Kun LuoDepartment of Cardiology, Union Hospital, Fujian Institute of Coronary Artery Disease, Fujian Medical University FuzhouP. R. China
,
Lin FanDepartment of Cardiology, Union Hospital, Fujian Institute of Coronary Artery Disease, Fujian Medical University FuzhouP. R. China
,
Xian-feng DongDepartment of Cardiology, Union Hospital, Fujian Institute of Coronary Artery Disease, Fujian Medical University FuzhouP. R. China
&
Hong ZhengDepartment of Cardiology, Union Hospital, Fujian Institute of Coronary Artery Disease, Fujian Medical University FuzhouP. R. ChinaCorrespondence[email protected]
 show all
Pages 160-164 | Received 14 Oct 2012, Accepted 26 Dec 2012, Published online: 14 Feb 2013

Citations (35)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Moritz Mirna, Bernhard Wernly, Vera Paar, Christian Jung, Peter Jirak, Hans-Reiner Figulla, Daniel Kretzschmar, Marcus Franz, Uta C. Hoppe, Michael Lichtenauer & Alexander Lauten. (2018) Multi-biomarker analysis in patients after transcatheter aortic valve implantation (TAVI). Biomarkers 23:8, pages 773-780.
Read now

Articles from other publishers (34)

Vera Karamfilova, Iveta Nedeva, Tsvetan Gatev, Antoaneta Gateva, Yavor Assyov, Antonina Gerganova, Dobrin Popov, Tsvetelina Velikova & Zdravko Kamenov. (2023) Relationship of serum Fetuin-A with metabolic and vascular parameters in patients with prediabetes and type 2 diabetes mellitus. Pharmacia 70:4, pages 1455-1461.
Crossref
Marta Favero, Francesca Ometto, Elisa Belluzzi, Giacomo Cozzi, Laura Scagnellato, Francesca Oliviero, Pietro Ruggieri, Andrea Doria, Mariagrazia Lorenzin & Roberta Ramonda. (2023) Fetuin-A: A Novel Biomarker of Bone Damage in Early Axial Spondyloarthritis. Results of an Interim Analysis of the SPACE Study. International Journal of Molecular Sciences 24:4, pages 3203.
Crossref
Anna Kącka, Anna Charemska, Elżbieta Jarocka-Cyrta & Barbara Głowińska-Olszewska. (2022) Comparison of novel markers of metabolic complications and cardiovascular risk factors between obese non-diabetic and obese type 1 diabetic children and young adults. Frontiers in Endocrinology 13.
Crossref
Uğur TAŞKIN & Hakan TIKIZ. (2022) Obstrüktif Koroner Arter Hastalığı İle Serum 25-OH Vitamin D, Fetuin-A, Matrix Gla Protein Ve ADMA Düzeyleri Arasındaki İlişkiThe Relationship Between Obstructive Coronary Artery Disease and Serum 25-OH Vitamin D, Fetuin-A, Matrix Gla Protein, and ADMA Levels. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 9:3, pages 393-396.
Crossref
Endeshaw Chekol Abebe, Zelalem Tilahun Muche, Awigchew Behaile T/Mariam, Teklie Mengie Ayele, Melaku Mekonnen Agidew, Muluken Teshome Azezew, Edgeit Abebe Zewde, Tadesse Asmamaw Dejenie & Misganaw Asmamaw Mengstie. (2022) The structure, biosynthesis, and biological roles of fetuin-A: A review. Frontiers in Cell and Developmental Biology 10.
Crossref
Hakan Çakır, Selçuk Kanat, Hilal Çakır & Erhan Tenekecioğlu. (2021) Níveis mais Baixos de Fetuína-A Sérica estão Associados a um Maior Risco de Mortalidade em Dez Anos em Pacientes com Infarto do Miocárdio por Supradesnivelamento do Segmento ST. Arquivos Brasileiros de Cardiologia.
Crossref
Shilpa Suneja, Sukanya Gangopadhyay, Vandana Saini, Rajni Dawar & Charanjeet Kaur. (2021) Emerging Diabetic Novel Biomarkers of the 21st Century. Annals of the National Academy of Medical Sciences (India) 57:03, pages 69-81.
Crossref
Teoman Dogru, Ali Kirik, Hasan Gurel, Ali A. Rizvi, Manfredi Rizzo & Alper Sonmez. (2021) The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart. International Journal of Molecular Sciences 22:12, pages 6627.
Crossref
Reza Afrisham, Maliheh Paknejad, Davod Ilbeigi, Sahar Sadegh-Nejadi, Sattar Gorgani-Firuzjaee & Mahmoud Vahidi. (2021) Positive Correlation between Circulating Fetuin-A and Severity of Coronary Artery Disease in Men. Endocrine, Metabolic & Immune Disorders - Drug Targets 21:2, pages 338-344.
Crossref
Peter Jirak, Lars Stechemesser, Elena Moré, Michael Franzen, Albert Topf, Moritz Mirna, Vera Paar, Rudin Pistulli, Daniel Kretzschmar, Bernhard Wernly, Uta C. Hoppe, Michael Lichtenauer & Hermann Salmhofer. 2019. 79 130 .
Ahu Yilmaz, Tolga Yilmaz & Murat Gunay. (2017) Elevated serum fetuin-A levels are associated with grades of retinopathy in type 2 diabetic patients. International Ophthalmology 38:6, pages 2445-2450.
Crossref
Fen-Yu Tseng, Yen-Ting Chen, Yu-Chiao Chi, Pei-Lung Chen & Wei-Shiung Yang. (2018) Serum levels of fetuin-A are negatively associated with log transformation levels of thyroid-stimulating hormone in patients with hyperthyroidism or euthyroidism. Medicine 97:46, pages e13254.
Crossref
Danping Huang, Weiqu Yuan, Hanmin Li, Shaodong Li, Zuanguang Chen & Hongzhi Yang. (2018) Identification of key pathways and biomarkers in sorafenib‑resistant hepatocellular carcinoma using bioinformatics analysis. Experimental and Therapeutic Medicine.
Crossref
Satinath Mukhopadhyay, Deep Dutta & Dipyaman Ganguly. 2018. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome 181 191 .
F. Roshanzamir, M. Miraghajani, M. H. Rouhani, M. Mansourian, R. Ghiasvand & S. M. Safavi. (2017) The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies. Journal of Endocrinological Investigation 41:1, pages 33-47.
Crossref
Eleni Pappa, Despina S Perrea, Spiridon Pneumaticos & Vasileios S Nikolaou. (2017) Role of fetuin A in the diagnosis and treatment of joint arthritis. World Journal of Orthopedics 8:6, pages 461.
Crossref
Alexander Berezin. (2016) Is rationale to decrease serum osteoprotegerin and fetuin-A in type 2 diabetes mellitus patients?. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 10:3, pages 169-170.
Crossref
Zhong-Wei Zhou, Hui-Xiang Ju, Ming-Zhong Sun, Qing-Ping Fu, Hong-Mei Chen, Hong-Bin Ji, Fei Ji & Dong-Mei Jiang. (2016) Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy. Clinica Chimica Acta 455, pages 113-117.
Crossref
Chisato Naito, Mio Hashimoto, Kaho Watanabe, Remina Shirai, Yui Takahashi, Miho Kojima, Rena Watanabe, Kengo Sato, Yoshitaka Iso, Taka-aki Matsuyama, Hiroshi Suzuki, Hatsue Ishibashi-Ueda & Takuya Watanabe. (2016) Facilitatory effects of fetuin-A on atherosclerosis. Atherosclerosis 246, pages 344-351.
Crossref
Aydın Akyüz. 2016. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease 177 196 .
Anna Maria Dabrowska, Jerzy Stanislaw Tarach, Beata Wojtysiak-Duma & Dariusz Duma. (2015) Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature. Biomedical Papers 159:3, pages 352-359.
Crossref
YI XIANG, YI LIU, YIXUAN YANG, HUAIDONG HU, PENG HU, HONG REN & DAZHI ZHANG. (2015) A secretomic study on human hepatocellular carcinoma multiple drug-resistant cell lines. Oncology Reports 34:3, pages 1249-1260.
Crossref
S Topsakal, F Akin, S Turgut, GF Yaylali, D Herek & C Ayada. (2014) Relationship of apelin, procalcitonin, and fetuin-A concentrations with carotid intima-media thickness in acromegaly. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 52:4, pages 456-461.
Crossref
Fatih Akin, Omer Celik, Ibrahim Altun, Burak Ayca, Vesile Ornek Diker, Seckin Satılmıs & Cem Sahin. (2015) Relationship of fibroblast growth factor 23 and fetuin-A to coronary atherosclerosis. Journal of Diabetes and its Complications 29:4, pages 550-555.
Crossref
Xiang-sheng WangWen YangTong LuoJian-ming WangYan-yan Jing. (2015) Serum Endocan Levels Are Correlated with the Presence and Severity of Coronary Artery Disease in Patients with Hypertension. Genetic Testing and Molecular Biomarkers 19:3, pages 124-127.
Crossref
Jinmi LeeSeok-Woo HongSe Eun ParkEun-Jung RheeCheol-Young ParkKi-Won OhSung-Woo ParkWon-Young Lee. (2015) Exendin-4 Inhibits the Expression of SEPP1 and Fetuin-A via Improvement of Palmitic Acid-Induced Endoplasmic Reticulum Stress by AMPK. Endocrinology and Metabolism 30:2, pages 177.
Crossref
Zhongwei Zhou, Huixiang Ju, Mingzhong Sun, Hongmei Chen, Hongbin Ji, Dongmei Jiang, Yuqiao Ji & Jianwei Ji. (2015) Serum fetuin-A concentrations are positively associated with serum VEGF levels in patients with newly diagnosed type 2 diabetes. Endocrine Journal 62:10, pages 879-885.
Crossref
Rui Jiang. (2015) Relation of Serum and Vitreous Concentrations of Fetuin-A with Diabetic Retinopathy. Medical Science Monitor 21, pages 1839-1842.
Crossref
Aydın Akyüz. 2015. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease 1 20 .
Satinath Mukhopadhyay, Samim A. Mondal, Manoj Kumar & Deep Dutta. (2014) Proinflammatory and Antiinflammatory Attributes of Fetu Iν-A: A Novel Hepatokine Modulating Cardiovascular and Glycemic Outcomes in Metabolic Syndrome. Endocrine Practice 20:12, pages 1345-1351.
Crossref
D. Dutta, S. A. Mondal, M. Kumar, A. H. Hasanoor Reza, D. Biswas, P. Singh, S. Chakrabarti & S. Mukhopadhyay. (2014) Serum fetuin-A concentration predicts glycaemic outcomes in people with prediabetes: a prospective study from eastern India. Diabetic Medicine 31:12, pages 1594-1599.
Crossref
Nikolaos P. E. Kadoglou, George Kottas, Stylianos Lampropoulos, Ioulia Vitta & Christos D. Liapis. (2013) Serum Levels of Fetuin-A, Osteoprotegerin and Osteopontin in Patients with Coronary Artery Disease: Effects of Statin (HMGCoA-Reductase Inhibitor) Therapy. Clinical Drug Investigation 34:3, pages 165-171.
Crossref
Ze-Lin Sun, Qi-Ying Xie, Gong-Liang Guo, Ke Ma & Yuan-Yuan Huang. (2014) Serum Fetuin-A Levels in Patients with Cardiovascular Disease: A Meta-Analysis. BioMed Research International 2014, pages 1-9.
Crossref
Samarjit Das & Tengku Ain Kamalden. 2014. Diabetic Cardiomyopathy. Diabetic Cardiomyopathy 313 321 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.